]>
IRCT20201019049079N1 IRCT 2021-07-03 Kerman University of Medical Sciences MCT Oil in viral respiratory tract infection in patient with metabolic syndrome Investigating the effects of oral medium-chain triglyceride (MCT) on the process of disease symptoms in patients with viral respiratory tract infection in outpatients with metabolic syndrome 2021-06-05 anticipated 80 Complete https://irct.ir/trial/51727 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using Random Allocation Software, patients are randomly divided into intervention and control groups. The samples will be determined by random blocking method with 4 blocks and using the table of random numbers of Software Allocation Random software. Blocking and allocation sequencing for concealment will be done by the person not involved in the research (Allocation Concealment. The sample allocation ratio will be 1: 1 Allocation and will be placed in two groups receiving Iranian medicine products and control (Assignment. Will be given The study is Lable-Open and blinding will not happen. 3 Condition 1: COVID-19. Condition 2: Seasonal Influenza. Condition 3: Adult Cold. Intervention 1: Intervention group: To determine the effect of the substance mentioned in the text of Take 2 tablespoons of Medium-Chain Triglyceride oil after each meal for 7 days, and after this Action The healing process was examined chemical formula: Triglyceride with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms. This drug is not produced in the country. Intervention 2: Control group: No special intervention is performed. (Except filling out the questionnaire). Yes - There is a plan to make this available What will be shared: Measured variables are available after unidentifiable individuals. When: Up to one year after publish results. To whom: All people in the research centers. Conditions: Allowed for any use. Where to obtain: Mohammad Amin Fallah, 09135258850, amin.fallah44@gmail.com How to obtain: After contacting and knowing the identity of the person, information will be provided to them. Comments:
public Mohammad Amin Fallah Mehrizi
Afzalipoor Hospital
Kerman Iran (Islamic Republic of) 7617735967 +98 34 3325 7660 amin.fallah44@gmail.com Kerman University of Medical Sciences scientific Masoud Moghadari
Haft Bagh Alavi
Kerman Iran (Islamic Republic of) 7617735967 +98 34 3132 5820 masoudmoghaderi@gmail.com Kerman University of Medical Sciences Iran (Islamic Republic of) Informed consent Metabolic Syndrome as defined by the International Diabetes Federation (IDF): Abdominal obesity above 94 cm in men and 80 cm in women plus two of the following criteria: IFG above 100, triglyceride above 150, HDL below 40 in men and below 50 in women And have systolic blood pressure above 130 mmHg or diastole above 85 mmHg Symptoms of viral respiratory tract infection 18 years 70 years Both Drug allergy Pregnancy / breastfeeding Asthma and allergies CHF CRF malignancy Immune system defects such as AIDS and corticosteroids B97.29 Other coronavirus as the cause of diseases classified elsewhere Treatment - Drugs N/A Intervention group: To determine the effect of the substance mentioned in the text of Take 2 tablespoons of Medium-Chain Triglyceride oil after each meal for 7 days, and after this Action The healing process was examined chemical formula: Triglyceride with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms. This drug is not produced in the country. Control group: No special intervention is performed. (Except filling out the questionnaire) Symptoms of viral respiratory tract infection (fever, cough, body aches, shortness of breath). Timepoint: Days 0 (visit day) ,1,2,3,4,7 and 14. Method of measurement: Questionnaire and question from the patient. Kerman University of Medical Sciences Approved 2021-05-31 Ethics committee of Afzalipoor Hospital of Kerman Medical University pajoohesh square Kerman Kerman Iran (Islamic Republic of)